🇺🇸 FDA
Patent

US 9248113

Infusion and injection solution of Levodopa

granted A61KA61K31/198A61K47/02

Quick answer

US patent 9248113 (Infusion and injection solution of Levodopa) held by Dizlin Medical Design AB expires Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Dizlin Medical Design AB
Grant date
Tue Feb 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/198, A61K47/02, A61K47/12, A61K47/26